Nondrug therapy in the combination rehabilitation of patients with Parkinson’s disease

Non-drug rehabilitation in Parkinson’s disease (PD) has recently attracted the increasing attention of neurologists worldwide. Symptomatic medical treatment only prolongs the period of relative wellbeing and little affects the course of the disease, without preventing its progression. Today this raises the question of whether other or additional therapeutic approaches to rehabilitating patients with this disease should be sought. The elaboration and practical implementation of a program for multidisciplinary patient rehabilitation are most effective to date. This program includes combination therapy based on the use of current drugs and different variants of nondrug therapy. Within the current concept of medical treatment for PD, there are two strategic approaches: 1) to search for agents that are able to slow, delay, or stop its progression (the so-called neuroprotection) and 2) to develop more effective symptomatic therapies. The latter approach is presently considered to be basic. At large, more than 40-year experience in using dopaminergic and other antiparkinsonian agents indicates that this therapy cannot drastically solve the problem of PD treatment. So nondrug care methods whose improvement has become a relevant task of current therapeutic strategy in this disease are the focus of attention today. A nonpharmacological approach to treating PD is appropriate at all its stages. Here are just some of these methods: medicinal vacation, phototherapy, sleep deprivation, electroconvulsive therapy, and transcranial magnetic stimulation. Patients’ compliance to dietary advice is of significance. The experience shows that the most accessible and efficient and safe nondrug treatment is of course a package of measures to stimulate
and restore a patient’s physical activity, which encompasses special functional training programs, kinesitherapy, multisensory training,
physical exercises, etc. There is a need to further accumulate experience with nondrug therapy for PD to prove its therapeutic effectiveness and to promote its optimization.

1. Sapir S, Ramig L, Fox C. Voice, speech, and swallowing disorders. In: Handbook of Parkinson’s Diseasae. CRC Press; 2013. P. 539–69.

2. Sturkenboom I, Keus S, Munneke M, Bloem B. Physical and occupational therapy. In: Handbook of Parkinson’s Diseasae. CRC Press; 2013. P. 520–38.

3. Tan L, Methawasin K. Complementary and alternative medicine in Parkinson’s disease. In: Handbook of Parkinson’s Diseasae. CRC Press; 2013. P. 539–69.

4. Левин ОС, Федорова НВ. Болезнь Паркинсона. Москва: МЕДпресс-информ; 2012. 351 с. [Levin OS, Fedorova NV. Bolezn' Parkinsona [Parkinson's disease]. Moscow: MEDpress-inform; 2012. 351 p.]

5. Яхно НН, Нодель МР. Применение препарата Мирапекс при болезни Паркинсона. Методические рекомендации. Москва; 2000. 28 с. [Yakhno NN, Nodel' MR. Primenenie preparata Mirapeks pri bolezni Parkinsona. [Metodicheskie rekomendatsii Application of a preparation of Mirapeks at Parkinson’s disease. Methodical recommendations ]. Moscow; 2000. 28 p.]

6. Иллариошкин СН. Болезнь Паркинсона на современном этапе: нерешенные проблемы, вопросы ранней диагностики. Consilium Medicum. 2010;экстравыпуск:3–4. [Illarioshkin SN. Parkinson's illness at the present stage: unresolved problems, questions of early diagnostics. Consilium Medicum. 2010;Extra Issue:3–4. (In Russ.)]

7. Федорова НВ. Пролонгированный прамипексол в лечении болезни Паркинсона. Неврология, нейропсихиатрия, психосоматика. 2012;(1):112–6. [Fedorova NV. Sustained-release pramipexole in the treatment of Parkinson’s disease. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2012;(1):112–6. (In Russ.)]. DOI: http://dx.doi.org/10.14412/2074-2711-2012-373.

8. Левин ЯИ, Артеменко АР. Фототерапия. Москва; 1996. 80 с. [Levin YaI, Artemenko AR. Fototerapiya [Phototherapy]. Moscow; 1996. 80 p.]

9. Голубев ВЛ, Левин ЯИ, Вейн АМ. Болезнь Паркинсона и синдром паркинсонизма. Москва: МЕДпресс-информ; 2000. 416 с. [Golubev VL, Levin YaI, Vein AM. Bolezn' Parkinsona i sindrom parkinsonizma [Parkinson’s disease and syndrome of parkinsonism]. Moscow: MEDpress-inform; 2000. 416 p.]

10. Logroscino G, Mayeux R. Diet and Parkinson’s disease. Neurology. 1997;49(2):310–1. DOI: http://dx.doi.org/10.1212/WNL.49.1.310.

11. Никитин СС, Куренков АЛ. Магнитная стимуляция в диагностике и лечении болезней нервной системы. Москва: САШКО; 2003. 378 с. [Nikitin SS, Kurenkov AL. Magnitnaya stimulyatsiya v diagnostike i lechenii boleznei nervnoi sistemy [Magnetic stimulation in diagnostics and treatment of diseases of nervous system]. Moscow: SAShKO; 2003. 378 p.]

12. Wichmann R. Role of physical therapy in management of Parkinson’s disease. In: Parkinson’s disease. Pfeifer RF, Wszolek ZK, Ebady M, editors. CRC Press; 2013. Р. 937–44.

13. Pellecchia M, Grasso A, Biancardi L, et al. Physical therapy in Parkinson’s disease: an open long-term rehabilitation trial. J Neurol. 2004;251:595–8. DOI: http://dx.doi.org/10.1007/s00415-004-0379-2.

14. Pearson VA. Speech and language therapy: is it effective? Public Health. 1995;109:143–53. DOI: http://dx.doi.org/10.1016/S0033-3506(05)80008-3.

15. Камакинова ФБ, Голубев ВЛ. Кинезитерапия – базовый элемент нелекарственного лечения болезни Паркинсона. Журнал неврологии и психиатрии им. С.С. Корсакова. 2013;113(10):69–73. [Kamakinova FB, Golubev VL. Kinesitherapy is a basic element of non-pharmacological treatment of Parkinson’s disease. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2013;113(10):69–73. (In Russ.)]

16. Deane KH, Ellis-Hill C, Playford ED, et al. Occupational therapy for patients with Parkinson’s disease. Cochrane Database Syst Rev. 2001;(3):CD002813.

17. Deane KH, Jones D, Ellis-Hill C, et al. A comparison of physiotherapy techniques for patients with Parkinson’s disease. Cochrane Database Syst Rev. 2001;(1):CD002815.